InvestorsHub Logo
Followers 20
Posts 2595
Boards Moderated 0
Alias Born 01/27/2022

Re: golf stud post# 420272

Friday, 01/12/2024 10:13:56 AM

Friday, January 12, 2024 10:13:56 AM

Post# of 426233
They need a lot of things to go right to see more than $10-12.

They would NEED to capture Italy, France, and Germany. China to go very well (remember we just get a royalty). And they likely need to see some growth somehow in the U.S. - either through formulation change, authorized generic, legal maneuver against generics, additional indication (ie. BRAVE), etc.

$15 is a $6B+ market cap. $25 = $10B. That's aggressive without substantial U.S. revenues.

I'm not saying it can't happen. But a LOT of things need to go right.

FWIW, when I first invested, I was thinking $25 potential. Then we lost the patent and I was thinking $15. Then the Europe rollout became a much bigger challenge than expected, and I have drifted down to $10.

I agree and I have $15 as my number but could see $20 maybe even $25 if some real good things happen

I am in the camp that Brave will be positive enough to add value to the company and get us a few more $’s in a buyout so that’s where I can see $20 possibly $25 within the next 2 years or so

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News